Putnam BioRevolution ETF NVZMY Holdings History
Putnam BioRevolution ETF's Novonesis (Novozymes) B Holding Summary
As of 2025-04-30, Putnam ETF Trust held 4,140.00 shares of Novonesis (Novozymes) B(NVZMY), totaling $268,730.00. This investment constitutes 5.64% of their stock portfolio, and Putnam ETF Trust now holds 0% of the outstanding Novonesis (Novozymes) B(NVZMY) stock.
The initial trade took place in 2022Q4. And since then Putnam BioRevolution ETF has made 2 purchases of NVZMY, at an average price of $52.49, for a total of 4,140.00 shares. Based on historical transaction data and NVZMY's current price of $69.39, Putnam BioRevolution ETF's estimated gain on his NVZMY holdings is $69,985.38, reflecting a 32.21% gain to date.
Putnam BioRevolution ETF NVZMY ($69.39) Holding Chart
Putnam BioRevolution ETF NVZMY ($69.39) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
